Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor
申请人:High Point Pharmaceuticals, LLC
公开号:EP2243776A1
公开(公告)日:2010-10-27
A novel class of substituted piperidines, pharmaceutical compositions comprising them and use thereof in the treatment of disease and disorders related to the histamine H3 receptor. More particularly, the compounds are useful for the treatment of diseases and dis-orders in which an interaction with the histamine H3 receptor is beneficial.
一类新型取代的哌啶类化合物、包含它们的药物组合物及其在治疗与组胺 H3 受体有关的疾病和紊乱中的用途。更具体地说,这些化合物可用于治疗与组胺 H3 受体相互作用有益的疾病和紊乱。